Governor Kathy Hochul announced new regulations to govern Pharmacy Benefit Managers in New York. They aim to reduce prescription drug costs, increase transparency, and support small, independent pharmacies.
Johnson & Johnson has submitted an FDA application for the first subcutaneous IL-23 inhibitor for ulcerative colitis. This drug could offer patients a groundbreaking at-home treatment option.
A recent NACDS poll highlights strong voter support for PBM reform and the significant influence healthcare issues had on voters' decisions in the 2024 elections.
This is the latest move in a bitter legal fight between the three largest pharmacy benefit managers, or PBMs, in the U.S. and the FTC.
The latest Factbook reveals that approximately 95 percent of all pharmaceutical sales moved through the traditional distribution segment in 2023, among other key findings.
The announcement was made by CEO Kevin Murphy, who highlighted Stalbaum’s extensive experience and contributions to the company since joining in 2019.
Bruce Kneeland, Principal Consultant of Kneeland Services and industry expert, has joined Finch Marketing and GRX Marketing to drive its growth initiatives.
As part of National Diabetes Awareness Month, Cardinal Health is focusing on the Hispanic American population, which is one of the top high-risk populations for diabetes.
Oz said in a post on social media website X he was looking forward "to serving my country to Make America Healthy Again under" Kennedy's leadership.
Seven national companies awarded for performance in screening & prevention, care continuity and highest satisfaction.
With more drugstore and retail clinic closures announced, American consumers are worried about accessing affordable care nearby while many are more open to new technologies like AI chatbots and QR codes to support their medication needs.
Dr. Chaguturu replaces Mike Pykosz, who has decided to leave the company.
Through this rigorous accreditation process, CVS Health conveys its ability to meet these critical standards, reinforcing its role as a leader in advancing health equity.
Replenza is a cutting-edge support system created specifically for individuals using GLP-1 medications, which have gained widespread popularity for weight loss and management.
For the second year in a row, Walgreens has announced it will close most of its retail stores for the Thanksgiving holiday.
